tm logo
WHOLEHEMP & DESIGN
REGISTRATION PENDING

on 31 Dec 1969

Last Applicant/ Owned by

WHOLE HEMP ORGANICS INC.

1551 Caterpillar RdMississauga

ONTARIO

CA

L4X2Z6

Serial Number

1967384 filed on 06th Jun 2019

Correspondent Address

(Blaney McMurtry LLP)2 Queen Street East, Suite 1500Toronto

ONTARIO

CA

M5C3G5

WHOLEHEMP & DESIGN

Vienna Information


5 . 1 . 5

One tree or one bushUn arbre ou un arbuste

5 . 1 . 13

Trees or bushes with rootsArbres ou arbustes avec racines

5 . 1 . 16

Trees or bushes in stylized formArbres ou arbustes stylisés

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 16

More than four leaves, scattered leaves, bunches of leaves -- Note: Not including surfaces or backgrounds covered with a repeated figurative element composed of leaves (25.7.25).Plus de quatre feuilles, feuilles éparses, bouquets de feuilles -- Note: Non compris les surfaces ou fonds couverts d'un élément figuratif répété constitué de feuilles (25.7.25).

5 . 11 . 1

Algae, seaweeds and other plantsAlgues, varech et autres végétaux

5 . 11 . 2

Roots, radicles, ginsengsRacines, radicelles, ginseng

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 15

Circles or ellipses containing representations of animals, parts of animals' bodies or plantsCercles ou ellipses contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

5 . 1 . 3

Trees or bushes of some other shapeArbres ou arbustes présentant une autre forme

Trademark usage description

packaging of marijuana and derivative products of marijuana, namely food products, extracts, natural health products, medicinal preparations, pharmace Read More

Classification Information


Class [001]
Cannabinoids for use in the manufacture of food products, not medicinal; plant extracts for use in the manufacture of pharmaceuticals;


Classification kind code

11

Class [003]
Beauty care cosmetics containing cannabinoids; beauty care cosmetics containing cannabinoids; body and beauty care cosmetics containing cannabinoids; cannabidiol (CBD) derived from hemp for cosmetic purposes; cannabinoid oil for cosmetic purposes; cannabinoid oil for toiletry purposes; cosmetics containing cannabinoids; hemp oil for cosmetic purposes; hemp seed oil for cosmetic purposes; hemp-based body moisturizers; hemp-based CBD oils for cosmetic purposes; hemp-based cosmetics; hemp-based deodorant soaps; hemp-based deodorants for human beings; hemp-based essential oils; hemp-based hair conditioners; hemp-based hair shampoos; hemp-based hand creams; hemp-based lip balms; hemp-based shower gels; hemp-based shower oils; hemp-based skin cleansers; hemp-based skin serums; non-medicated skin care and toiletry preparations containing cannabinoids, namely, oils, ointments, serums, salves, balms, creams, lotions, gels, toners, cleaners, peels, and roll-on sticks; terpenes; terpenes being essential oils;


Classification kind code

11

Class [005]
Anti-diabetic pharmaceuticals; anti-epileptic pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; antidiabetic pharmaceuticals; antiepileptic pharmaceutical preparations; antifungal pharmaceutical preparations; antiviral pharmaceutical preparations; botanical supplements for general health and well-being; cannabidiol (CBD) derived from hemp for medicinal purposes; cannabidiol [CBD] oil for medical purposes; cannabidiol for medical purposes; cannabinoid oil for medicinal purposes; cannabis capsules for maintaining general health and well-being; cannabis oil for maintaining general health and well-being; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; dietary and nutritional supplements for general health and well being; dietary and nutritional supplements for general health and wellbeing; dietary and nutritional supplements for pets for heart health; dietary pet supplements containing cannabinoids in the form of pet treats and pet food; dietary supplement drink mixes for general health and wellbeing; dietary supplements for general health and well-being; dietary supplements for humans containing cannabinoids for medicinal purposes; dietary supplements for humans containing cannabinoids for recreational purposes ; dietary supplements for pets for general health and wellbeing; dietary, nutritional and herbal supplements for general health and well-being; dietetic food and substances adapted for medical and veterinary use containing cannabinoids; gummy vitamins containing cannabinoids for medicinal purposes; gummy vitamins containing cannabinoids for recreational purposes; gummy vitamins containing cannabinoids for recreational purposes ; hemp oil for medicinal purposes; hemp seed oil for medicinal purposes; hemp-based dietary supplements; hemp-based food supplements; hemp-based nutritional supplements; hemp-based powder dietary supplements; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the relief of pain; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhaled pharmaceutical preparations for treating respiratory diseases and disorders; medicated cosmetics containing cannabinoids; medicated skin care and toiletry preparations containing cannabinoids, namely, oils, ointments, serums, salves, balms, creams, lotions, gels, toners, cleaners, peels, and roll-on sticks; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceuticals containing cannabis for maintaining general health and well being; nutraceuticals for use as a dietary supplement for general health and well-being; nutritional supplemental meal replacement bars containing cannabinoids; nutritional supplements containing cannabinoids for medicinal purposes; nutritional supplements containing cannabinoids for recreational purposes ; nutritional supplements containing cannabinoids, namely, oral sprays, tinctures, gummies, and recovery shots for medicinal purposes; nutritional supplements containing cannabinoids, namely, oral sprays, tinctures, gummies, and recovery shots for recreational purposes; nutritional supplements for general health and well being; nutritional supplements for general health and well-being; nutritional supplements for general health and well-being, dietary supplements for general health and well-being, herbal supplements for general health and well-being; nutritional supplements in the form of gummies for general health and well-being; oral sprays containing cannabis for maintaining general health and well-being; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the prevention of diabetes; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of diabetes; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for controlling cholesterol; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for inducing erections; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for maintaining normal blood pressure and heart function; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of iron deficiency and anaemia in humans; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of muscular atrophy; pharmaceutical preparations for the prevention and treatment of renal disease and disorders; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of chronic liver diseases; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of cystic fibrosis; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; pharmaceutical preparations for the treatment of dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and bacterial skin infections and fungal skin infections.; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of duchenne muscular dystrophy; pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of eye infections; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of mastitis; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of multiple sclerosis, namely, topical creams containing cannabidiol; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases and osteoporosis; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic conditions; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of primary hyperoxaluria; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of tuberculosis; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating digestive system disorders; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating high cholesterol; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in immunomodulation therapies; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in the treatment of autoinflammatory diseases; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for use in the treatment of musculoskeletal diseases; pharmaceutical preparations for use in urology; pharmaceutical preparations namely, anti-inflammatories; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceuticals for ophthalmological use; pharmaceuticals for the prevention and treatment of cancer; pharmaceuticals for the treatment of bone diseases; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals for treating the symptoms of radiation sickness; pills, tablets, sublingual doses and dissolvable strips containing cannabis for maintaining general health and well-being; synthetic cannabinoids for medical purposes; tetrahydrocannabinol for medical purposes; transdermal patches containing cannabis for maintaining general health and well being; vitamin preparations containing cannabinoids for medicinal purposes; vitamin preparations containing cannabinoids for recreational purposes ;


Classification kind code

11

Class [010]
Medical devices for the administration of cannabinoids, and parts and fittings therefore;


Classification kind code

11

Class [022]
Hemp;


Classification kind code

11

Class [029]
Fruit bars; cannabinoid oil for human consumption; edible oils containing cannabinoids; fruit-based snack food containing cannabinoids; gluten-free snack food containing cannabinoids; hemp milk; hemp milk-based beverages; hemp oil for food; hemp seed oil for food; jams containing cannabinoids; nut-based snack food containing cannabinoids; prepared hemp seeds; vegetable-based snack food containing cannabinoids;


Classification kind code

11

Class [030]
Cookies, cakes, pastries, brownies, candies, cereal-based bars, chocolate, chocolate bars, energy bars, food energy bars; teas; granola-based snack bars; cereal-based snack foods containing cannabinoids ; chocolate confectionery containing cannabinoids; chocolate containing cannabinoids; corn-based snack foods containing cannabinoids; energy bars containing cannabinoids; flour containing cannabinoids; grain-based snack foods containing cannabinoids; granola-based snack foods containing cannabinoids; honey infused with cannabinoids; processed hemp seeds for use as seasoning; rice-based snack foods containing cannabinoids; sugar confectionery containing cannabinoids; tea-based beverages containing cannabinoids; wheat-based snack foods containing cannabinoids;


Classification kind code

11

Class [031]
Live cannabis plants; live hemp plants; unprocessed hemp seeds; live marijuana plants


Classification kind code

11

Class [032]
Smoothies, fruit beverages, fruit juices, carbonated soft drinks, energy drinks; energy drinks containing cannabinoids; flavored waters containing cannabinoids; fruit beverages and fruit juices containing cannabinoids; fruit-based beverages containing cannabinoids; hemp-flavored beer; mineral and aerated waters containing cannabinoids; non-alcoholic hemp-based fruit beverages; non-alcoholic hemp-based smoothies; powder containing cannabinoids used in the preparation of energy drinks; powder containing cannabinoids used in the preparation of soft drinks; powder containing cannabinoids used in the preparation of flavored waters; powder containing cannabinoids used in the preparation of fruit juices; powder containing cannabinoids used in the preparation of fruit-based drinks; powder containing cannabinoids used in the preparation of sports drinks; smoothies containing cannabinoids; sports drinks containing cannabinoids; vegetable-based beverages containing cannabinoids;


Classification kind code

11

Class [034]
Cannabidiol (CBD) derived from hemp for smoking purposes; cannabidiol [CBD] oil for electronic cigarettes; cannabinoid oil for electronic cigarettes; cannabinoid oil for oral vaporizers for smoking; dried cannabis; dried marijuana; electronic cigarette liquid (e-liquid) comprised of flavorings in liquid form containing cannabinoids; electronic cigarettes containing oil infused with cannabinoids; hemp cigarettes; oral vaporizer cartridges sold filled with electronic cigarette liquid (e-liquid) flavorings containing cannabinoids; vaping pens for smoking purposes containing cannabinoids; liquid solutions for use in e-cigarettes; apparatus for use of cannabis and marijuana, namely rolling papers, pipes, vapourizers


Classification kind code

11

Class [035]
Marketing for others, namely promotion and advertising for others of treatments for diseases or conditions using cannabis, and promotion and advertising of products used in the administration or use of cannabis for others; selling, retail, dispensing, wholesale and distribution of marijuana and derivative products of marijuana, namely food products, extracts, natural health products, medicinal preparations, pharmaceutical preparations, concentrates, pastes, namely pastes, creams and ointments, and oils; marketing for others, namely promotion and advertising for others of treatments for diseases or conditions using marijuana, and promotion and advertising of products used in the administration or use of marijuana for others; selling, retail, dispensing, wholesale and distribution of cannabis and derivative products of cannabis, namely food products, extracts, natural health products, medicinal preparations, pharmaceutical preparations, concentrates, pastes, namely pastes, creams and ointments, and oils; selling, retail, wholesale and distribution of marijuana and cannabis paraphernalia, namely rolling papers, pipes, vapourizers, medical equipment, and parts and fittings therefor; selling, retail, wholesale and distribution of apparatus for use of cannabis and marijuana, namely rolling papers, pipes, vapourizers, medical equipment, and parts and fittings therefor


Classification kind code

11

Class [039]
Packaging of marijuana and derivative products of marijuana, namely food products, extracts, natural health products, medicinal preparations, pharmaceutical preparations, and concentrates; packaging of cannabis and derivative products of cannabis, namely food products, extracts, natural health products, medicinal preparations, pharmaceutical preparations, and concentrates; destruction of cannabis and marijuana


Classification kind code

11

Class [040]
Manufacturing of marijuana and cannabis and derivative products of marijuana and cannabis, namely food products, extracts, nutriceuticals, nutritional supplements, dietary supplements, medicinal preparations, pharmaceutical preparations, and concentrates, for others; destruction of cannabis and marijuana for others


Classification kind code

11

Class [041]
Educational services, namely providing information relating to medical cannabis and medical marijuana


Classification kind code

11

Class [042]
Research related to medical cannabis and medical marijuana; providing information in the field of medical cannabis and medical marijuana via website;


Classification kind code

11

Class [044]
Growing, cultivating and harvesting cannabis and cannabis seeds; operation of a medical marijuana and medical cannabis dispensary; cultivating of marijuana and cannabis and derivative products of marijuana and cannabis, namely food products, extracts, nutriceuticals, nutritional supplements, dietary supplements, medicinal preparations, pharmaceutical preparations, and concentrates, for others;


Classification kind code

11

Mark Details


Serial Number

1967384

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 15
on 28th Sep 2022
Correspondence Created
Submitted for opposition 23
on 17th Dec 2021
Default Removed
Submitted for opposition 15
on 17th Dec 2021
Correspondence Created
Submitted for opposition 14
on 29th Jun 2021
Default Notice Sent
Submitted for opposition 15
on 08th Dec 2020
Correspondence Created
Submitted for opposition 22
on 19th Nov 2019
Search Recorded
Submitted for opposition 20
on 19th Nov 2019
Examiner's First Report
Submitted for opposition 31
on 10th Jun 2019
Formalized
Submitted for opposition 1
on 07th Jun 2019
Created
Submitted for opposition 30
on 06th Jun 2019
Filed